ClinicalTrials.gg

Supplement

(R)-3-hydroxybutyl (R)-3-hydroxybutyrate clinical trials

studies test it
24
open now
8
in phase 3
0
first study started
2011

Keep track of what changes. Save the (R)-3-hydroxybutyl (R)-3-hydroxybutyrate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

24 studies that test it; most in 2024 (4)

Studies that test (R)-3-hydroxybutyl (R)-3-hydroxybutyrate, by start year
YearStudies
20111
20161
20182
20192
20201
20213
20223
20232
20244
20252
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
2
Phase 2
3
Phase 4
2
No phase
16

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 0 · Other 24

University of British Columbia (4) · University of Alabama at Birmingham (3) · University of Oxford (2) · University of Aarhus (2) · McMaster University (2) · Central Jutland Regional Hospital (1) · National Institute on Aging (NIA) (1) · Barts & The London NHS Trust (1)

Studies

Open first, then newest update. How each study uses (R)-3-hydroxybutyl (R)-3-hydroxybutyrate is read from its arms, and is right about nine times in ten.

Testing it · 24

See all 24 studies that test (R)-3-hydroxybutyl (R)-3-hydroxybutyrate →

As the comparator · 1 — what is tested is compared with (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

Codes

What other systems call (R)-3-hydroxybutyl (R)-3-hydroxybutyrate · ClinicalTrials.gg INT006190

  • MeSH (NLM) C576699(R)-3-hydroxybutyl (R)-3-hydroxybutyrateOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.